Boya Bio-Pharmaceutical Group

Boya Bio-Pharmaceutical Group Co., Ltd. is a Chinese company specializing in the research, development, production, and distribution of blood products and various health-related products. The company offers a range of blood products, including human fibrinogen, intravenous human immunoglobulin, rabies immunoglobulin, and human albumin. Additionally, it provides a wide array of medications across several therapeutic areas, such as orthopedics, obstetrics and gynecology, gastrointestinal health, and diabetes management. Boya also produces active pharmaceutical ingredients and chemical raw materials, contributing to its diverse portfolio. Founded in 1993 and headquartered in Fuzhou, China, the company was formerly known as Jiangxi Boya Bio-Pharmaceutical Co., Ltd. and rebranded in August 2017. Boya Bio-Pharmaceutical Group is committed to integrating biochemical drugs, chemical medicines, and active pharmaceutical ingredients to enhance healthcare outcomes.